Michael Tesar
23Patents
10h-index
33Co-inventors
75Inventor score
Filing activity: Dec 16, 1996 → Oct 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088896B2 | Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 62 | Active |
| US8337850B2 | 4-1BB binding molecules | Chemistry; Metallurgy | 56 | Active |
| US8821867B2 | 4-1BB binding molecules | Chemistry; Metallurgy | 50 | Active |
| US5867920A | High speed infrared/convection dryer | Mechanical Engineering; Lighting; Heating | 30 | Expired |
| US9468678B2 | Method of producing 4-1BB binding molecules and associated nucleic acids | Chemistry; Metallurgy | 27 | Active |
| US6213758A | Burner air/fuel ratio regulation method and apparatus | Mechanical Engineering; Lighting; Heating | 26 | Expired |
| US8263746B2 | Anti-CD38 human antibodies and uses thereof | Chemistry; Metallurgy | 23 | Active |
| US9200061B2 | Generation and profiling of fully human HuCAL gold®-derived therapeutic antibodies specific for human CD3i | Chemistry; Metallurgy | 13 | Active |
| US6067726A | High speed infrared/convection dryer | Mechanical Engineering; Lighting; Heating | 12 | Expired |
| US9758590B2 | Anti-CD38 human antibodies and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US7521047B2 | Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells | Chemistry; Metallurgy | 7 | Expired |
| US8486394B2 | Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 4 | Active |
| US7033544B2 | Determination of supplemental fuel requirement and instantaneous control thereof involving regenerative thermal oxidation | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5762880A | Operational process and its improved control system of a secondary air burner | Emerging Cross-Sectional Technologies | 4 | Expired |
| US9193799B2 | Fully human therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 3 | Active |
| US10640568B2 | 4-1BB binding molecules | Chemistry; Metallurgy | 2 | Active |
| US10184005B2 | Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 2 | Active |
| US11059902B2 | Generation and profiling of fully human HuCAL GOLD-derived therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 1 | Active |
| US11510972B2 | Bispecific EGFR/CD16 antigen-binding protein | Chemistry; Metallurgy | 1 | Active |
| US11001633B2 | NK cell engaging antibody fusion constructs | Chemistry; Metallurgy | 0 | Active |
| US9873733B2 | Anti-staphylococcal antibodies | Chemistry; Metallurgy | 0 | Active |
| US11939395B2 | Generation and profiling of fully human HuCAL gold-derived therapeutic antibodies specific for human CD38 | Chemistry; Metallurgy | 0 | Active |
| US12076384B2 | Bispecific EGFR/CD16 antigen-binding protein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.